Vascular, renal, and endocrine responses to low-dose atrial natriuretic peptide in the fluid-balanced New Zealand genetically hypertensive rats with and without endogenous arginine vasopressin

Canadian Journal of Physiology and Pharmacology

Volumn 77, Issue 2, 1999, Pages 102-110

  Abu Amarah, Isam ^a   Balment, Richard J ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Arginine vasopressin; Atrial natriuretic peptide; Hypertension; Renal

Indexed keywords

ALDOSTERONE; ANGIOTENSIN; ARGIPRESSIN; ATRIAL NATRIURETIC FACTOR; CHLORIDE; CORTICOSTERONE; ELECTROLYTE; HORMONE; RENIN; SODIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIURESIS; DOSE RESPONSE; ELECTROLYTE EXCRETION; FLUID BALANCE; GENETIC DISORDER; GLOMERULUS FILTRATION RATE; HYPERTENSION; HYPOTENSION; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY CLEARANCE; MALE; MEAN ARTERIAL PRESSURE; NATRIURESIS; NONHUMAN; PRIORITY JOURNAL; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

EID: 0032803006     PISSN: 00084212     EISSN: None     Source Type: Journal    
DOI: 10.1139/y98-152     Document Type: Article

References (25)

1. Al-Barazanji, K.A., and Balment, R.J. 1989. Central and peripheral effects of the peptide ANF on the renal function and blood pressure in hypertensive rats. J. Physiol. (London), 418: 261-271.
2. Al-Barazanji, K.A., and Balment, R.J. 1995. Renal, endocrine and vascular effects of atrial natriuretic peptide in a novel vasopressin-deficient genetically hypertensive strain of rat. Exp. Physiol. 80: 275-284.
3. Ashton, N., and Balment, R.J. 1989a. Renal and blood pressure changes in response to vasopressin antagonism in the New Zealand genetically hypertensive rat. Acta Endocrinol. 74: 230-236.
4. Ashton, N., and Balment, R.J. 1989b. Blood pressure and renal function in a novel vasopressin-deficient, genetically hypertensive rat strain. J. Physiol. (London), 410: 21-34.
5. Awazu, M., Granger, J.P., and Knox, F.G. 1988. Natriuretic effect of atrial natriuretic peptide in diabetes insipidus rats. Proc. Soc. Exp. Biol. Med. 187: 165-168.
6. Burgess, W., and Balment, R.J. 1992. Plasma atrial natriuretic peptide in vasopressin deficiency: the effects of acute water deprivation in rats. J. Endocrinol. 135(3): 431-438.
7. Burgess, W., Shalmi, M., Petersen, J., Plange-Rhule, J., Balment, R., and Atherton, J.C. 1993. A novel computer-driven, servo-controlled fluid replacement technique and its application to renal function studies in conscious rats. Clin. Sci. 85: 129-137.
8. Charles, C.J., Espiner, E.A., Nichols, M.G., Richards, A.M., Yandle, T.G., Protter, A., and Kosgolou, T. 1996. Clearance receptors and endopeptidase 24.11: equal role in natriuretic peptide metabolism in conscious sheep. Am. J. Physiol. 271: R373-R380.
9. Crofton, J.T., Share, L., Baer, P.G., Allen, C.M., and Wang, B.C. 1981. Vasopressin secretion in the New Zealand genetically hypertensive rat. Clin. Exp. Hypertens. 3: 975-989.
10. Debinski, W.K., Kuchel, O.G., and Thibault, G. 1989. Increased neural atrial natriuretic factor generation in spontaneously hypertensive rats. Hypertension (Dallas), 13: 804-807.
11. Garcia, R., Gauquelin, G., Thibault, G., Cantin, M., and Schiffrin, E.L. 1989. Glomerular atrial natriuretic factor receptors in spontaneously hypertensive rats. Hypertension (Dallas), 13: 567-574.
12. Gerstberger, R., Schutz, H., Luther-Dyroff, D., Keil, R., and Simon, E. 1992. Inhibition of vasopressin and aldosterone release by atrial natriuretic peptide in conscious rabbits. Exp. Physiol. 77(4): 587-600.
13. 3-transport in the rat CCD: rapid adaptation by in vivo but not in vitro alkalosis. Am. J. Physiol. 264: F435-F440.
14. Jin, H., Chen, Y.-F., Yang, R.H., and Oparol, S. 1989. Atrial natriuretic factor in NaCl-sensitive and NaCl-resistant spontaneously hypertensive rats. Hypertension (Dallas), 14: 404-412.
15. Maack, T., Okolcany, J., Koh, G.Y., and Price, D.A. 1993. Functional properties of atrial natriuretic factor receptors. Semin. Nephrol. 13(1): 50-60.
16. Mann, W.A., and Kinter, L.B. 1993. Characterization of maximal intravenous dose volumes in the dog (Canis familiaris). Gen. Pharmacol. 24(2): 357-366.
17. Milne, C.M., Balment, R.J., Henderson, I.W., Mosley, W., and Chester Jones, I.C. 1982. Adrenocortical function in the Brattleboro rat. Ann. N.Y. Acad. Sci. 394: 230-239.
18. Mirenda, J.V., and Grissom, T.E. 1991. Anaesthetic implications of the renin-angiotensin system and angiotensin-converting enzyme inhibitors. Anesth. Analg. 72: 667-683.
19. Paul, R.V., Ferguson, T., and Navar, L.G. 1988. ANF secretion and renal responses to volume expansion with equilibrated blood. Am. J. Physiol. 255: F936-F931.
20. Phelan, E.L. 1968. The New Zealand hypertensive strain of rats with genetic hypertension. N.Z. Med. J. 67: 334-344.
21. Phelan, E.L., and Simpson, F.O. 1987. The New Zealand strain of genetically hypertensive rats. Hypertension (Dallas), 9(Suppl. I): I15-I17 and I40-I42.
22. Smirk, F.H., and Hall, W.H. 1958. Inherited hypertension in rats. Nature (London), 158: 727-728.
23. Tremblay, J., Hoot, C., Willenbrock, R.C., Bayard, F., Gossard, F., Fujio, N., Koch, C., Kochel, O., Debinski, W., and Hamet, P. 1993. Increased cyclic guanosine monophosphate production and overexpression of atrial natriuretic peptide A-receptor mRNa in spontaneously hypertensive rats. J. Clin. Invest. 92(5): 2499-2508.
24. Walker, L.A., Buscemi-Bergin, M., and Gellai, M. 1983. Renal haemodynamics in conscious rats: effects of anaesthesia, surgery, and recovery. Am. J. Physiol. 245: F67-F74.
25. Yamamoto, S., Morimoto, I., Yanagihara, N., Kangawa, K., Inenaga, K., Eto, S., and Yamashita, H. 1997. C-type natriuretic peptide suppresses arginine-vasopressin secretion from dissociated magnocellular neurons in newborn rat supra optic nucleus. Neurosci. Lett. 229(2): 97-100.